Maria Buti

Maria Buti

UNVERIFIED PROFILE

Are you Maria Buti?   Register this Author

Register author
Maria Buti

Maria Buti

Publications by authors named "Maria Buti"

Are you Maria Buti?   Register this Author

100Publications

3278Reads

13Profile Views

Too many people with viral hepatitis are diagnosed late - with dire consequences.

Nat Rev Gastroenterol Hepatol 2019 Aug;16(8):451-452

Liver Unit, Vall d'Hebron Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41575-019-0177-zDOI Listing
August 2019

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study.

Lancet Gastroenterol Hepatol 2019 Jul 9;4(7):538-544. Epub 2019 Apr 9.

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, Netherlands; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30087-1DOI Listing
July 2019

Decompensated Liver Disease due to Primary Hepatic Amyloidosis: Is Liver Transplantation Still Mandatory?

Hepatology 2019 Jun 7;69(6):2701-2703. Epub 2019 Mar 7.

Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30464DOI Listing
June 2019

Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?

J Hepatol 2019 Mar 28;70(3):564-566. Epub 2018 Nov 28.

Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.10.020DOI Listing
March 2019

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH).

Gastroenterol Hepatol 2018 Nov 27;41(9):597-608. Epub 2018 Sep 27.

Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, España; Grupo para el Estudio de las Hepatitis Víricas, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gastrohep.2018.07.010DOI Listing
November 2018

Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.

Transfusion 2018 11 4;58(11):2501-2505. Epub 2018 Oct 4.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.14831DOI Listing
November 2018

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant.

Infect Drug Resist 2018 8;11:2207-2210. Epub 2018 Nov 8.

Liver Unit, Liver Disease Laboratory-Viral Hepatitis, Internal Medicine Department, Vall d'Hebron Institut of Research (VHIR)-Vall d'Hebron University Hospital(HUVH), 08035, Barcelona, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IDR.S172226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233951PMC
November 2018

Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy.

Antiviral Res 2018 10 29;158:34-44. Epub 2018 Jul 29.

Liver Pathology Unit, Departments of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona (UAB), 119-129 Passeig Vall d'Hebron, Clinical Laboratories, 08035 Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 3-5 Avenida Monforte de Lemos, pavilion 11, 28029 Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2018.07.019DOI Listing
October 2018

The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs.

Expert Rev Clin Pharmacol 2018 Oct 29;11(10):999-1030. Epub 2018 Sep 29.

e Liver Unit , Hospital Universitario Vall d'Hebron and Ciber-ehd, Instituto Carlos III , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1519392DOI Listing
October 2018

HDV evolution-will viral resistance be an issue in HDV infection?

Curr Opin Virol 2018 10 8;32:100-107. Epub 2018 Nov 8.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain; Liver Pathology Unit, Departments of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coviro.2018.10.003DOI Listing
October 2018

Erratum to "A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction" [J Hepatol 67 (2017) 669-679].

J Hepatol 2018 07;69(1):262-264

Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Calle Irunlarrea 3, Pamplona 31008, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.04.003DOI Listing
July 2018

A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?

Ann Hepatol 2017 Jul-Aug;16(4):630-632

Liver Unit, Department of Internal Medicine. Instituto de Salud Carlos III, Madrid. Spain.

View Article

Download full-text PDF

Source
http://annalsofhepatology.publisherspanel.com/gicid/01.3001.
Publisher Site
http://dx.doi.org/10.5604/01.3001.0010.0314DOI Listing
April 2018

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.

Gastroenterology 2018 03 13;154(4):976-988.e4. Epub 2017 Nov 13.

Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt, Germany, German Center for Infection Research (DZIF), External Partner Site Frankfurt, Germany; Medizinische Klinik II, St. Josefs-Hospital, Wiesbaden, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.11.007DOI Listing
March 2018

Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B.

Liver Int 2018 Feb;38 Suppl 1:84-89

Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13641DOI Listing
February 2018

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population.

World J Gastroenterol 2018 Feb;24(6):680-692

Liver Pathology Unit, Departments of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona 08035, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v24.i6.680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807671PMC
February 2018

Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy.

Antivir Ther 2016 17;21(2):153-9. Epub 2015 Sep 17.

Department of Pharmacy, Radboud university medical center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2994DOI Listing
January 2018

Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing.

Virus Res 2018 01 4;243:52-59. Epub 2017 Oct 4.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain; Liver Pathology Unit, Departments of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virusres.2017.10.003DOI Listing
January 2018

New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors.

J Gen Virol 2018 Jan 14;99(1):97-102. Epub 2017 Dec 14.

1​Liver Unit, Liver Disease Laboratory-Viral Hepatitis, Internal Medicine Department, Vall d'Hebron Institut Recerca (VHIR)-Hospital Universitari Vall d'Hebron (HUVH), 08035, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/jgv.0.000996DOI Listing
January 2018

Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.

J Infect Dis 2017 11;216(suppl_8):S792-S796

Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona.

View Article

Download full-text PDF

Source
http://academic.oup.com/jid/article/216/suppl_8/S792/4636134
Publisher Site
http://dx.doi.org/10.1093/infdis/jix135DOI Listing
November 2017

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B.

Ann Hepatol 2017 May - Jun;16(3):358-365

Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/16652681.1235478DOI Listing
October 2017

A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.

J Hepatol 2017 10 18;67(4):669-679. Epub 2017 May 18.

Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Calle Irunlarrea 3, Pamplona 31008, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.05.010DOI Listing
October 2017

The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis.

Transplantation 2017 05;101(5):987-995

1 Division of Gastroenterology/Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. 2 Harvard Medical School, Boston, MA. 3 Liver Unit, Department of Internal Medicine, Hospital Valle Hebron and Ciberehd del Institut Carlos III, Barcelona, Spain. 4 Hepatology, University Clinic for Visceral Surgery and Medicine, Inselspital, University of Berne, Switzerland. 5 Division of Gastroenterology/Hepatology, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000001400DOI Listing
May 2017

Successful Continuation of HCV Treatment After Liver Transplantation.

Transplantation 2017 05;101(5):1009-1012

1 Liver Unit, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHIM, CIBERehd, Majadahonda, Madrid, Spain. 2 Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain. 3 Liver Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebron, CIBERehd, Barcelona, Spain. 4 Hepatology and Liver Transplant Unit, Hospital Universitario Reina Sofía, IMIBIC, CIBERehd, Córdoba, Spain. 5 Gastroenterology and Hepatology Unit, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain. 6 Digestive Service, Hospital Universitario 12 de Octubre, Madrid, Spain. 7 Liver Unit, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid and CIBERehd, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000001596DOI Listing
May 2017

Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.

Ann Hepatol 2019 Jan - Feb;18(1):215-219

Liver Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/01.3001.0012.7916DOI Listing
May 2017

Hepatitis C virus infection.

Nat Rev Dis Primers 2017 Mar 2;3:17006. Epub 2017 Mar 2.

Beatty Center for Integrated Research, Falls Church, Virginia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2017.6DOI Listing
March 2017

Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report.

Transfusion 2017 02 26;57(2):244-247. Epub 2016 Oct 26.

Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13876DOI Listing
February 2017

Management of direct antiviral agent failures.

Clin Mol Hepatol 2016 Dec 25;22(4):432-438. Epub 2016 Dec 25.

Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2016.0107
Publisher Site
http://dx.doi.org/10.3350/cmh.2016.0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266337PMC
December 2016

Hepatitis C Therapy: Game Over!

Gastroenterology 2016 11 1;151(5):795-798. Epub 2016 Oct 1.

Liver Unit, Hospital General Universitario Valle Hebron and Ciberehd del Instituto Carlos III, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.09.034DOI Listing
November 2016

New real-time-PCR method to identify single point mutations in hepatitis C virus.

World J Gastroenterol 2016 Nov;22(43):9604-9612

Qian Chen, Maria Buti, Damir Garcia-Cehic, Josep Gregori, Celia Perales, Laura Ordeig, Meritxell Llorens, Maria Eugenia Soria, Rafael Esteban, Juan Ignacio Esteban, Josep Quer, Liver Unit, Internal Medicine, Lab. Malalties Hepàtiques, Vall d'Hebron Institut Recerca-Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i43.9604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116604PMC
November 2016

Baseline HCV-RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut-off points.

Hepatology 2016 10 26;64(4):1385-6. Epub 2016 Apr 26.

Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28544DOI Listing
October 2016

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.

J Clin Gastroenterol 2016 10;50(9):779-89

*Genetic of Metabolic Diseases Laboratory, Institute of Medical and Molecular Genetics (INGEMM), Madrid †Department of Hepatology, Hospital Universitario La Paz/Carlos III, CIBEREHD §Department of Hepatology, Hosp. Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, CIBEREHD §§Department of Digestive Diseases, Hosp. de Alcorcón ***Department of Digestive Diseases, Hosp. Infanta Sofía †††Department of Nephrology, Hosp. 12 Octubre, Madrid ‡Digestive Medicine Service, Hospital Universitari i Politécnic La Fe, and CIBEREHD ¶¶¶Department of Digestive Diseases, Hosp. General de Valencia, Valencia ∥Department of Digestive Diseases, Hosp. Virgen del Rocío, IBIS, CIBEREHD §§§Department of Digestive Diseases, Hosp. de Valme, CIBEREHD, Sevilla ¶Departament of Digestive Disease, Hospital Universitario La Coruña ###División of Clinical Virology, INIBIC-Complejo Hospitalario Universitario de A Coruña (CHUAC), SERGAS, Universidade da Coruña, A Coruña #Gastroenterology and Hepatology Unit, Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander **Department of Hepatology, Hosp. Univ. Vall d´Hebrón, CIBEREHD ∥∥Liver Section, Hospital del Mar. IMIM. Universitat Autónoma de Barcelona, Barcelona ††Hosp. Univ. Son Espases, Palma de Mallorca ‡‡Department of Digestive Diseases, Hosp. Univ. Donostia, Donostia ¶¶Department of Digestive Diseases, Hosp. Reina Sofía, Córdoba ##Department of Hepatology, Hospital Universitario Central de Asturias, Oviedo ‡‡‡Department of Reumathology, Hosp. Univ. Salamanca, Salamanca ∥∥∥CIBEREHD and Hepatology Unit, Hospital Germans Trias i Pujol, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000569DOI Listing
October 2016

A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?

Ann Hepatol 2017 Jul - Aug;16(4):630-632

Liver Unit, Department of Internal Medicine. Instituto de Salud Carlos III, Madrid. Spain. Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona. Spain. Instituto de Salud Carlos III, Madrid. Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid. Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/01.3001.0010.0314DOI Listing
October 2016

Patient experience in HCV therapy: what really matters.

Lancet Gastroenterol Hepatol 2016 10 3;1(2):90-92. Epub 2016 Aug 3.

Liver Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona 08035, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(16)30020-6DOI Listing
October 2016

Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.

Eur J Gastroenterol Hepatol 2016 Aug;28(8):923-6

aJ.W. Goethe University Hospital, Frankfurt am Main bBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach cBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany dThe Liver Institute at Methodist Dallas Medical Center, Dallas eCentral Texas Clinical Research, Austin, Texas fNorthwest Indiana Center for Clinical Research, Valparaiso, Indiana gScripps Clinic, La Jolla, California hBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA iHospital Carlos III, Madrid jHospital Universitario Valle de Hebrón and CIBERehd del Instituto Carlos III, Barcelona, Spain kUniversity Clinic for Visceral Surgery and Medicine, University of Bern, Bern, Switzerland lAustin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000649DOI Listing
August 2016

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B.

Ann Hepatol 2017 May - Jun;16(3):358-365

Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/01.3001.0009.8590DOI Listing
August 2016

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus.

PLoS One 2015 29;10(12):e0144816. Epub 2015 Dec 29.

Liver Pathology Unit, Departments of Biochemistry and Microbiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144816PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695080PMC
July 2016

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

Clin Infect Dis 2016 Jan 14;62(1):32-6. Epub 2015 Sep 14.

Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/civ722DOI Listing
January 2016

Management of direct-acting antiviral agent failures.

J Hepatol 2015 Dec 20;63(6):1511-22. Epub 2015 Aug 20.

Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.08.010DOI Listing
December 2015

Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?

Gastroenterology 2015 Nov 28;149(6):1326-30. Epub 2015 Sep 28.

Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.09.032DOI Listing
November 2015

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Cancer 2015 Oct 15;121(20):3631-8. Epub 2015 Jul 15.

Hepatology Service, Beaujon Hospital, Paris-Diderot University and INSERM CRI/UMR 1149, Viral Hepatitis Research Centre, Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29537DOI Listing
October 2015

Tenofovir discontinuation after long-term viral suppression in HBeAg negative chronic hepatitis B. Can HBsAg levels be useful?

J Clin Virol 2015 Jul 8;68:61-8. Epub 2015 May 8.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2015.05.002DOI Listing
July 2015

Profiles and clinical management of hepatitis C patients in Spain: disHCovery study.

Rev Esp Quimioter 2015 Jun;28(3):145-53

Maria Buti, Internal Medicine and Hepatology, Hospital Vall d´Hebron and Ciberehd del Institut Carlos III, Passeig de la Vall d´Hebron 119, Barcelona, 08035 Spain.

View Article

Download full-text PDF

Source
June 2015